Beyfortus 100 MG/ML syringeml
Ended Awarded
- Contract number
- SPE2DB26FJRXD
- Awardee
-
DMS Pharmaceutical Group Inc. UEI PX72BSBQTKJ3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $36,142
Award facts
- Contract value 100% obligated
- $36,141.60 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Park Ridge, IL 60068, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a delivery order valued at $36,141.60 to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler headquartered in Park Ridge, Illinois, for the supply of Beyfortus 100 mg/ml syringes. This firm fixed-price delivery order, issued without set-aside designation, was awarded on October 31, 2025, with an ultimate completion date of November 3, 2025. The award represents a continuation of DMS Pharmaceutical Group's substantial pharmaceutical supply relationship with the Defense Logistics Agency, which has issued the company numerous delivery orders spanning diverse therapeutic categories and product lines to support Department of Defense medical supply requirements.
This delivery order is issued under DMS Pharmaceutical Group's Indefinite Delivery Contract with the Defense Logistics Agency's Pharmaceutical Prime Vendor Global Program Generation V (PPV-G GEN V) initiative, a $30.3 billion acquisition strategy designed to establish regional prime vendor contractors for comprehensive pharmaceutical supply. The company's underlying IDC, designated SPE2DR and awarded November 13, 2025, carries a ceiling value of $499,999,999 and extends through December 31, 2036, with a 30-month base period and three 30-month option periods. This contract structure positions DMS Pharmaceutical Group as a critical pharmaceutical supplier for Department of Defense healthcare operations, enabling the agency to issue firm fixed-price delivery orders for branded and generic prescription drugs, biologics, and medical consumables to military healthcare facilities worldwide.
Quick answers
Who was awarded contract SPE2DB26FJRXD?
SPE2DB26FJRXD was awarded to DMS Pharmaceutical Group Inc. by Defense Logistics Agency (Department of Defense) on October 31, 2025.
How much is contract SPE2DB26FJRXD worth?
The government has obligated $36,142 on SPE2DB26FJRXD.
Is contract SPE2DB26FJRXD an order under another contract?
Yes. SPE2DB26FJRXD is a delivery order under SPE2DB24D9803, an indefinite delivery contract.
Was contract SPE2DB26FJRXD competed?
The extent of competition for SPE2DB26FJRXD was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award